Skip to content

POC4TRIAGE-shEEG

Point-of-Care Devices for Urgent Care Triage – Subhairline Electroencephalography for Stroke Detection - POC4TRIAGE-shEEG

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58130
Enrollment
467
Registered
2025-02-12
Start date
2025-12-03
Completion date
Unknown
Last updated
2026-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, cerebrovascular accident Stroke

Interventions

The StrokePointer shEEG device, with electroencephalography electrodes below the hairline for detection of stroke

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, all subjects must meet the following criterion: - Age of 18 years or older - Written informed consent Furthermore, suspected stroke patients must meet all of the following criteria: - Suspected stroke as per judgement of the ambulance personnel or a confirmed LVO stroke - Onset of symptoms or last seen well <24 hours before shEEG data acquisition

Exclusion criteria

Exclusion criteria: - Skin defect or active infection of the scalp in the area of electrode placement

Design outcomes

Primary

MeasureTime frame
A shEEG-based AI-algorithm with optimal diagnostic accuracy for the detection of LVO stroke of the anterior circulation among patients with a suspected stroke. The final diagnosis of all patients will be established by an adjudication committee, which will consist of a vascular neurologist and neuroradiologist, and will be based on available clinical and imaging data. For the purpose of the study, an LVO stoke is defined as an occlusion of: - Intracranial part of the internal carotid artery (ICA) - First segment or proximal part of the second segment of the middle cerebral artery (M1 and proximal M2, respectively) - First segment of the anterior cerebral artery (A1)

Secondary

MeasureTime frame
The secondary study endpoints include: - The user-friendliness rating of the StrokePointer shEEG device by ambulance personnel in terms of EEG recording preparation time, usability of the StrokePointer shEEG patch (scored as XX ) and usability of the StrokePointer shEEG software (scored as XX) - Safety assessment of the StrokePointer shEEG device, i.e. the number of serious adverse device-related events and the number of healthy subjects and patients with an (allergic) skin reaction observed at the placement area of the shEEG patch - The proportion of suspected stroke patients with a technically successful shEEG dataset, i.e. at least 10 seconds of shEEG data with no to minimal artifacts, in the ER and prehospital setting - The diagnostic accuracy of existing EEG-based algorithms and the newly developed shEEG-based AI-algorithm for LVO stroke detection among patients with a suspected stroke, as measured with AUC as well as sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) - The diagnostic accuracy of existing shEEG-based algorithms and newly developed shEEG-based AI-algorithms for the detection of LVO stroke of the posterior circulation, intracerebral hemorrhage, transient ischemic attack and stroke mimics, as measured with AUC as well as sensitivity, specificity, PPV and NPV - The diagnostic accuracy of existing EEG-based algorithms in combination with clinical scales for LVO stroke detection among patients with a suspected stroke, as measured with AUC as well as sensitivity, specificity, PPV and NPV - Differences between shEEG electrodes and conventional EEG electrodes in signal quality, noise level and power spectral density  

Countries

Netherlands

Contacts

Public ContactM.J. Spaaks

Amsterdam UMC

m.j.spaaks@amsterdamumc.nl+31 20 566 2004

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 22, 2026